70 related articles for article (PubMed ID: 23489277)
1. Use of free circulating DNA for diagnosis, prognosis and treatment of cancer.
Sirera R; Camps C
Expert Opin Med Diagn; 2007 Sep; 1(1):143-6. PubMed ID: 23489277
[TBL] [Abstract][Full Text] [Related]
2. An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.
Kirsch C; Weickmann S; Schmidt B; Fleischhacker M
Ann N Y Acad Sci; 2008 Aug; 1137():135-9. PubMed ID: 18837937
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
4. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
van der Vaart M; Pretorius PJ
Clin Biochem; 2010 Jan; 43(1-2):26-36. PubMed ID: 19747472
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
[TBL] [Abstract][Full Text] [Related]
6. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.
van der Drift MA; Hol BE; Klaassen CH; Prinsen CF; van Aarssen YA; Donders R; van der Stappen JW; Dekhuijzen PN; van der Heijden HF; Thunnissen FB
Lung Cancer; 2010 May; 68(2):283-7. PubMed ID: 19632736
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
9. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
10. Circulating free tumor DNA and colorectal cancer.
Lecomte T; Ceze N; Dorval E; Laurent-Puig P
Gastroenterol Clin Biol; 2010 Dec; 34(12):662-81. PubMed ID: 20832215
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA in the circulation as a potential cancer biomarker.
Kohler C; Barekati Z; Radpour R; Zhong XY
Anticancer Res; 2011 Aug; 31(8):2623-8. PubMed ID: 21778314
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
Barton CA; Hacker NF; Clark SJ; O'Brien PM
Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
[TBL] [Abstract][Full Text] [Related]
13. Gene methylation and early detection of genitourinary cancer: the road ahead.
Cairns P
Nat Rev Cancer; 2007 Jul; 7(7):531-43. PubMed ID: 17585333
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic developments involving cell-free (circulating) nucleic acids.
Tong YK; Lo YM
Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
[TBL] [Abstract][Full Text] [Related]
16. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
[TBL] [Abstract][Full Text] [Related]
17. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
[TBL] [Abstract][Full Text] [Related]
20. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
Martins AT; Monteiro P; Ramalho-Carvalho J; Costa VL; Dinis-Ribeiro M; Leal C; Henrique R; Jerónimo C
Breast Cancer Res Treat; 2011 Aug; 129(1):1-9. PubMed ID: 20842524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]